All 1 tracked stories fall under one category: pharma. Reome is most often covered alongside Biodance, which appears in 1 of these 1 story. Each carries 2 original sources on average. We currently track 1 Biotech story that mention Reome, all published on August 12, 2026.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Reome
All 1 tracked stories fall under one category: pharma. Reome is most often covered alongside Biodance, which appears in 1 of these 1 story. Each carries 2 original sources on average. We currently track 1 Biotech story that mention Reome, all published on August 12, 2026.
Stories tracked
1
Sources per story
2
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 11 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Reome. Shared-story counts are live from our verified record — not editorial picks.
Biotech beauty leverages fermentation and living microorganisms to create products that bridge the gap between cosmetics and therapeutics. This has deep implications for drug delivery approaches, regulatory classification, and potential pharma partnerships as startups apply wound-healing science to everyday skincare.